play_arrow

keyboard_arrow_right

skip_previous play_arrow skip_next
00:00 00:00
playlist_play chevron_left
volume_up
  • Home
  • keyboard_arrow_right Podcast
  • keyboard_arrow_rightPodcasts
  • keyboard_arrow_right The Future of Psilocybin Therapy with Josh Bartch, CEO of Medicine Innovation Group on Gamechangers®
play_arrow

Podcast

The Future of Psilocybin Therapy with Josh Bartch, CEO of Medicine Innovation Group on Gamechangers®

Sergio Tigera January 6, 2022


Background
share close

In this episode we talk about the future of Psilocybin in therapeutics and how Mydecine is developing innovative first- and second-generation novel therapeutics for the treatment of mental health and addiction through world-class technology and drug development infrastructure. Mr. Bartch’s entrepreneurial career took off in 2009 when he co-founded AudioTranscriptionist.com and founded the Denver-based dispensary, Doctors Orders. Following these ventures, Mr. Bartch founded a boutique investment firm that operated throughout the U.S. and Canadian markets. In 2014, Bartch co-founded Cannabase.io, the U.S.’s most significant legal and sophisticated cannabis wholesale platform. Mr. Bartch took successful exits from AudioTranscriptionist.com, Doctor’s Orders, and Cannabase.io

Previous episode